Related references
Note: Only part of the references are listed.Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancer
Laetitia Fend et al.
ONCOIMMUNOLOGY (2017)
NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients
Sylvie Rusakiewicz et al.
ONCOIMMUNOLOGY (2017)
Targeting the tumor microenvironment to improve natural killer cell-based immunotherapies: On being in the right place at the right time, with resilience
Shannon Murray et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy
Zeynep Eroglu et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2016)
MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade
Peter J. R. Ebert et al.
IMMUNITY (2016)
Decreased NK-cell tumour immunosurveillance consequent to JAK inhibition enhances metastasis in breast cancer models
Alessia Bottos et al.
NATURE COMMUNICATIONS (2016)
Cytokines can counteract the inhibitory effect of MEK-i on NK-cell function
Claudia Manzini et al.
ONCOTARGET (2016)
Phenotypic and Functional Dysregulated Blood NK cells in colorectal cancer Patients can Be activated by cetuximab Plus IL-2 or IL-15
Yamila Sol Rocca et al.
FRONTIERS IN IMMUNOLOGY (2016)
NKp30 isoforms and NKp46 transcripts in metastatic melanoma patients: Unique NKp30 pattern in rare melanoma patients with favorable evolution
Meriem Messaoudene et al.
ONCOIMMUNOLOGY (2016)
Defective NK Cells in Acute Myeloid Leukemia Patients at Diagnosis Are Associated with Blast Transcriptional Signatures of Immune Evasion
Zena Khaznadar et al.
JOURNAL OF IMMUNOLOGY (2015)
Therapeutic potential and challenges of natural killer cells in treatment of solid tumors
Andrea Gras Navarro et al.
FRONTIERS IN IMMUNOLOGY (2015)
Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma
B. Schilling et al.
ANNALS OF ONCOLOGY (2014)
Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies
Holbrook E. Kohrt et al.
BLOOD (2014)
Mature Cytotoxic CD56(bright)/CD16(+) Natural Killer Cells Can Infiltrate Lymph Nodes Adjacent to Metastatic Melanoma
Meriem Messaoudene et al.
CANCER RESEARCH (2014)
Natural Killer Cells Are Essential for the Ability of BRAF Inhibitors to Control BRAFV600E-Mutant Metastatic Melanoma
Lucas Ferrari de Andrade et al.
CANCER RESEARCH (2014)
Acute myeloid leukemia impairs natural killer cells through the formation of a deficient cytotoxic immunological synapse
Zena Khaznadar et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy
Mahiuddin Ahmed et al.
FEBS LETTERS (2014)
Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia
Kate Stringaris et al.
HAEMATOLOGICA (2014)
A novel anti-CD19 monoclonal antibody (GBR 401) with high killing activity against B cell malignancies
Caroline S. Breton et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
CD56brightPerforinlow Noncytotoxic Human NK Cells Are Abundant in Both Healthy and Neoplastic Solid Tissues and Recirculate to Secondary Lymphoid Organs via Afferent Lymph
Paolo Carrega et al.
JOURNAL OF IMMUNOLOGY (2014)
Cancer-inducecd alterations of NK-mediated target recognition: current and investigational pharmacological strategies aiming at restoring NK-mediated anti-tumor activity
Anne-Sophie Chretien et al.
FRONTIERS IN IMMUNOLOGY (2014)
Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors
Sylvie Rusakiewicz et al.
CANCER RESEARCH (2013)
NK cells in immunotolerant organs
Haoyu Sun et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin
Romain Remark et al.
CLINICAL CANCER RESEARCH (2013)
Host immunity contributes to the anti-melanoma activity of BRAF inhibitors
Deborah A. Knight et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Phenotypic and Functional Characteristics of Blood Natural Killer Cells from Melanoma Patients at Different Clinical Stages
Giulia Fregni et al.
PLOS ONE (2013)
Innate lymphoid cells - a proposal for uniform nomenclature
Hergen Spits et al.
NATURE REVIEWS IMMUNOLOGY (2013)
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
Norbert Vey et al.
BLOOD (2012)
A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma
Don M. Benson et al.
BLOOD (2012)
Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients
Beatriz Sanchez-Correa et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Natural killer cell immune escape in acute myeloid leukemia
E. Lion et al.
LEUKEMIA (2012)
Selective BRAF inhibition decreases tumor-resident lymphocyte frequencies in a mouse model of human melanoma
Anna I. Hooijkaas et al.
ONCOIMMUNOLOGY (2012)
Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivo
Nai-Kong V. Cheung et al.
ONCOIMMUNOLOGY (2012)
Natural Innate and Adaptive Immunity to Cancer
Matthew D. Vesely et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
被撤回的出版物: CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies (Retracted article. See vol. 134, pg. 658, 2019)
Holbrook E. Kohrt et al.
BLOOD (2011)
IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect
Don M. Benson et al.
BLOOD (2011)
Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
Sophia Platonova et al.
CANCER RESEARCH (2011)
Natural Killer Cells are Scarce in Colorectal Carcinoma Tissue Despite High Levels of Chemokines and Cytokines
Niels Halama et al.
CLINICAL CANCER RESEARCH (2011)
Association between natural killer cells and regression in melanocytic lesions
Kristopher McKay et al.
HUMAN PATHOLOGY (2011)
Clinical Cancer Therapy by NK Cells via Antibody-Dependent Cell-Mediated Cytotoxicity
Kory L. Alderson et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
Emilie Mamessier et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Differential internalization of hu14.18-IL2 immunocytokine by NK and tumor cell: impact on conjugation, cytotoxicity, and targeting
Ilia N. Buhtoiarov et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
The Stage Dependent Changes in NK Cell Activity and the Expression of Activating and Inhibitory NK Cell Receptors in Melanoma Patients
Katarina Mirjacic Martinovic et al.
JOURNAL OF SURGICAL RESEARCH (2011)
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors
Nicolas F. Delahaye et al.
NATURE MEDICINE (2011)
Donor KIR Genes 2DL5A, 2DSI and 3DSI Are Associated with a Reduced Rate of Leukemia Relapse After HLA-Identical Sibling Stem Cell Transplantation for Acute Myeloid Leukemia but Not Other Hematologic Malignancies
Kate Stringaris et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia
Sarah Cooley et al.
BLOOD (2010)
Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function
Andrea Boni et al.
CANCER RESEARCH (2010)
The Oncogenic BRAF Kinase Inhibitor PLX4032/RG7204 Does Not Affect the Viability or Function of Human Lymphocytes across a Wide Range of Concentrations
Begona Comin-Anduix et al.
CLINICAL CANCER RESEARCH (2010)
In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients
Gordana Konjevic et al.
MELANOMA RESEARCH (2010)
Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells
Francois Romagne et al.
BLOOD (2009)
The impact of Fc engineering on an anti-CD19 antibody: increased Fcγ receptor affinity enhances B-cell clearing in nonhuman primates
Jonathan Zalevsky et al.
BLOOD (2009)
Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions
Trinidad Garcia-Iglesias et al.
BMC CANCER (2009)
Characterization of the intra-prostatic immune cell infiltration in androgen-deprived prostate cancer patients
Philippe O. Gannon et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
Intratumoral But Not Systemic Delivery of CpG Oligodeoxynucleotide Augments the Efficacy of Anti-CD20 Monoclonal Antibody Therapy Against B Cell Lymphoma
David J. Betting et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo
Caroline Sola et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy
Nadia Guerra et al.
IMMUNITY (2008)
Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy
Liat Binyamin et al.
JOURNAL OF IMMUNOLOGY (2008)
Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia
B. N. Savani et al.
LEUKEMIA (2007)
Membrane-bound interleukin (IL)-15 on renal tumor cells rescues natural killer cells from IL-2 starvation-induced apoptosis
Sebastian Wittnebel et al.
CANCER RESEARCH (2007)
Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients
Gordana Konjevic et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction
Cyril Fauriat et al.
BLOOD (2007)
Impact of immune parameters on long-term survival in metastatic renal cell carcinoma
F Donskov et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Identification of the NKG2D haplotypes associated with natural cytotoxic activity of peripheral blood lymphocytes and cancer immunosurveillance
T Hayashi et al.
CANCER RESEARCH (2006)
Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias
DW Beelen et al.
BLOOD (2005)
IL-21 induces the functional maturation of murine NK cells
J Brady et al.
JOURNAL OF IMMUNOLOGY (2004)
Unravelling natural killer cell function: triggering and inhibitory human NK receptors
L Moretta et al.
EMBO JOURNAL (2004)
The three Es of cancer immunoediting
GP Dunn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Roles of the NKG2D immunoreceptor and its ligands
DH Raulet
NATURE REVIEWS IMMUNOLOGY (2003)
Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia
RT Costello et al.
BLOOD (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer
FR Villegas et al.
LUNG CANCER (2002)
The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma
I Takanami et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2001)
Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population
K Imai et al.
LANCET (2000)
Share Paper
